Autoimmunity initiates in nonhematopoietic cells and progresses via lymphocytes in an interferon-dependent autoimmune disease.

Autoimmunity initiates in nonhematopoietic cells and progresses via lymphocytes in an interferon-dependent autoimmune disease.
复制标题

DOI:
10.1016/j.immuni.2011.11.018
复制
发表时间:
2012-01-27
期刊:
影响因子:
32.4
通讯作者:
Stetson DB
Stetson DB
中科院分区:
医学1区
文献类型:
--
作者:
Gall A;Treuting P;Elkon KB;Loo YM;Gale M Jr;Barber GN;Stetson DB

文献摘要

参考文献

被引文献

相似文献

通过检测核酸引发的I型干扰素(IFN)对抗病毒防御很重要,但也与特定的自身免疫性疾病有关。在这里,我们证明TREX1是依赖sting的抗病毒反应的基本负调节剂。介绍了组织损害。 TREX1缺陷小鼠自身免疫性疾病的逐步进展,对AGS和相关疾病的治疗产生了影响。
The type I interferon (IFN) response initiated by detection of nucleic acids is important for antiviral defense, but is also associated with specific autoimmune diseases. Mutations in the human 3′ repair exonuclease 1 (Trex1) gene cause Aicardi-Goutières syndrome (AGS), an IFN-associated autoimmune disease. However, the source of the type I IFN response and the precise mechanisms of disease in AGS remain unknown. Here, we demonstrate that Trex1 is an essential negative regulator of the STING-dependent antiviral response. We used an in vivo reporter of IFN activity in Trex1-deficient mice to localize the initiation of disease to non-hematopoietic cells. These IFNs drove T cell-mediated inflammation and an autoantibody response that targeted abundant, tissue-restricted autoantigens. However, B cells contributed to mortality independently of T cell-mediated tissue damage. These findings reveal a stepwise progression of autoimmune disease in Trex1-deficient mice, with implications for the treatment of AGS and related disorders.
DOI: 10.1016/j.cell.2008.06.032
发表时间: 2008-08-22
期刊: Cell
影响因子: 64.5
作者:
Stetson DB;Ko JS;Heidmann T;Medzhitov R
通讯作者: Medzhitov R
DOI: 10.1086/513443
发表时间: 2007-04-01
影响因子: 9.8
作者:
Rice, Gillian;Newman, William G.;Crow, Yanick J.
通讯作者: Crow, Yanick J.
DOI: 10.1038/ni.1779
发表时间: 2009-10
期刊: Nature immunology
影响因子: 30.5
作者:
通讯作者: --
DOI: 10.1084/jem.20050821
发表时间: 2005-09-05
期刊: The Journal of experimental medicine
影响因子: --
作者:
Kolumam GA;Thomas S;Thompson LJ;Sprent J;Murali-Krishna K
通讯作者: Murali-Krishna K
DOI: 10.1038/nri2587
发表时间: 2009-08
期刊: Nature reviews. Immunology
影响因子: --
作者:
通讯作者: --